Literature DB >> 7959682

Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma.

V Greger1, N Debus, D Lohmann, W Höpping, E Passarge, B Horsthemke.   

Abstract

The retinoblastoma susceptibility (RB1) gene contains an unmethylated CpG-rich island at its 5' end. Using methylation-sensitive restriction enzymes, we have investigated the methylation status of this island in 21 sporadic unilateral retinoblastomas and 30 hereditary retinoblastomas. Three sporadic unilateral tumors were found to have hypermethylated RB1 alleles. In two tumors, the paternal allele was methylated, whereas the maternal allele had been lost. Cultured cells from one of these tumors were studied by the reverse transcription polymerase chain reaction and found to have a reduced level of RB1 mRNA. The third tumor had retained constitutional heterozygosity, and the paternal allele was specifically methylated. The combined data from previously published reports and from this study show that hypermethylation of the RB1 gene occurs in 13% of sporadic unilateral tumors and may reduce gene activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959682     DOI: 10.1007/BF00211013

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  18 in total

1.  Detection of small RB1 gene deletions in retinoblastoma by multiplex PCR and high-resolution gel electrophoresis.

Authors:  D Lohmann; B Horsthemke; G Gillessen-Kaesbach; F H Stefani; H Höfler
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

2.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

Review 3.  The inheritance of epigenetic defects.

Authors:  R Holliday
Journal:  Science       Date:  1987-10-09       Impact factor: 47.728

4.  CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene.

Authors:  N Ohtani-Fujita; T Fujita; A Aoike; N E Osifchin; P D Robbins; T Sakai
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

5.  Interclonal variation in methylation patterns for expressed and non-expressed genes.

Authors:  R J Shmookler Reis; S Goldstein
Journal:  Nucleic Acids Res       Date:  1982-07-24       Impact factor: 16.971

6.  Characterization of deletions at the retinoblastoma locus in patients with bilateral retinoblastoma.

Authors:  K Kloss; P Währisch; V Greger; E Messmer; H Fritze; W Höpping; E Passarge; B Horsthemke
Journal:  Am J Med Genet       Date:  1991-05-01

7.  Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma.

Authors:  V Greger; E Passarge; W Höpping; E Messmer; B Horsthemke
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

8.  Newly established human retinoblastoma cell lines exhibit an "immortalized" but not an invasive phenotype in vitro.

Authors:  S Griegel; C Hong; R Frötschl; D F Hülser; V Greger; B Horsthemke; M F Rajewsky
Journal:  Int J Cancer       Date:  1990-07-15       Impact factor: 7.396

Review 9.  Genetics and cytogenetics of retinoblastoma.

Authors:  B Horsthemke
Journal:  Cancer Genet Cytogenet       Date:  1992-10-01

10.  No evidence for sequences structurally related to the RB1 gene in the human genome.

Authors:  C Belka; V Greger; B Zabel; B Horsthemke
Journal:  Hum Genet       Date:  1991-02       Impact factor: 4.132

View more
  46 in total

1.  DNA methylation and carcinogenesis in digestive neoplasms.

Authors:  Javed Yakoob; Xue-Gong Fan; Guo-Ling Hu; Zheng Zhang
Journal:  World J Gastroenterol       Date:  1998-04       Impact factor: 5.742

2.  Two new mutations and three novel polymorphisms in the RB1 gene in Ecuadorian patients.

Authors:  Paola E Leone; María Elena Vega; Paola Jervis; Angel Pestaña; Javier Alonso; César Paz-Y-Miño
Journal:  J Hum Genet       Date:  2003-11-19       Impact factor: 3.172

3.  A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus.

Authors:  Michael Zeschnigk; Stefan Böhringer; Elizabeth Ann Price; Zerrin Onadim; Lars Masshöfer; Dietmar R Lohmann
Journal:  Nucleic Acids Res       Date:  2004-09-07       Impact factor: 16.971

4.  The spectrum of RB1 germ-line mutations in hereditary retinoblastoma.

Authors:  D R Lohmann; B Brandt; W Höpping; E Passarge; B Horsthemke
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

5.  Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma.

Authors:  D R Lohmann; M Gerick; B Brandt; U Oelschläger; B Lorenz; E Passarge; B Horsthemke
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

Review 6.  Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.

Authors:  Mahmoud Alhosin; Tanveer Sharif; Marc Mousli; Nelly Etienne-Selloum; Guy Fuhrmann; Valérie B Schini-Kerth; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2011-04-15

Review 7.  Epigenetic regulation of human retinoblastoma.

Authors:  Usha Singh; Manzoor Ahmad Malik; Sandeep Goswami; Swati Shukla; Jasbir Kaur
Journal:  Tumour Biol       Date:  2016-09-17

8.  Bilateral retinoblastoma in a male patient with an X; 13 translocation: evidence for silencing of the RB1 gene by the spreading of X inactivation.

Authors:  C Jones; C Booth; D Rita; L Jazmines; B Brandt; A Newlan; B Horsthemke
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 9.  Altered DNA methylation and genome instability: a new pathway to cancer?

Authors:  P A Jones; M L Gonzalgo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 10.  Imprinting disorders and assisted reproductive technology.

Authors:  Carter M Owen; James H Segars
Journal:  Semin Reprod Med       Date:  2009-08-26       Impact factor: 1.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.